Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis - Wikidata - thesis-toulmin - TriplyDB

Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

http://www.wikidata.org/entity/Q35818801

about

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas Advances in sarcoma diagnostics and treatment FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.Intratumoral oxygen gradients mediate sarcoma cell invasion Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.YAP/TAZ at the Roots of Cancer.Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.YAP and the Hippo pathway in pediatric cancer.Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy TAZ and YAP are frequently activated oncoproteins in sarcomas.Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.Dual roles of yes-associated protein (YAP) in colorectal cancer.p53 shades of Hippo.miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma Soft Tissue Sarcoma Cancer Stem Cells: An Overview A comprehensive evaluation of Hippo pathway silencing in sarcomas

P2860

Q26782842-1604EFD5-4DC4-4E89-A6F4-60B0660BCC37 Q28069695-0FCACAE0-1A2C-4634-9AF2-6476FADC40E0 Q28076296-31B1CFB0-6D18-4670-BEB4-8AC2F9BD955C Q36882572-5235D4CF-18B8-42D7-A0AD-E012B107A3E7 Q37199989-97DB4B11-B501-4E80-8172-69BE56CF3CA1 Q37741081-16B457CB-EDA6-4915-8FFF-4F77D396282D Q38728339-FAF77067-6E0B-4200-850D-E2157725635F Q38864941-75A388CE-4E5F-4673-87D5-427FD9BEC0B1 Q39003420-53718050-2434-4D95-BDD4-D1763A7D6C13 Q39374990-8A90CACA-1C88-4496-AC3C-E6E845500467 Q39984948-CDDDD4AA-7CED-4ED2-AC70-D4C44CAA5B13 Q41416961-3CB1F5DC-A16D-438B-88A4-04714B09B566 Q41698570-7B0D8696-F9F2-4E9C-B247-3B8C8C004987 Q43651454-2A99DCA8-B8B5-4177-8D31-2A3C5548CA10 Q47850800-2C1F8639-DE10-4877-8003-4C01001F540D Q47879122-A7A7563D-E0F8-4EF3-9601-B907455665EC Q57646291-D9BCAD8E-9C57-411B-93DB-6EC426DF4F17 Q58707604-2638E163-146C-40E6-AFDD-6BB13E8558EB Q58801087-5B4C7DE8-DC9C-4F02-9973-E7F94A81D558

P2860

Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

http://www.wikidata.org/entity/Q35818801

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@ast

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@en

type

label

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@ast

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@en

prefLabel

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@ast

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@en

P1433

Q35818801-01425B2B-7BD3-47C9-829E-00976C7528C0

P1476

Q35818801-04A4E4C5-5D4B-464F-8453-330C62EFFB35

P2093

Q35818801-03861DAD-7AD8-44D4-9E7B-51669DB47D53

Q35818801-0B8C98C6-89E0-4241-8D44-E1ABD385B97E

Q35818801-5520A710-61CD-42F6-B758-A69ECDD21FF3

Q35818801-7235E58A-17CE-4A00-A86F-3887E2B6854B

Q35818801-83D5428F-AB63-4A2D-A066-13DA177D80DA

Q35818801-86B46EF1-6C5F-4039-8C56-C015A7FFBDC7

Q35818801-B7DB7BD0-B8AA-4666-A645-463619CEA84A

Q35818801-CD43C5CA-815F-4FEB-B30E-A9AFC1C3E041

Q35818801-F9CF0294-C968-4B80-AF31-D38F2A97372C

Q35818801-FA231B7E-A4BD-415F-926D-F916B954E7C4

P2860

Q35818801-0226396F-BA84-4858-B322-C6EE7955F840

Q35818801-06DDF0DA-A435-4666-B9B9-C3807ABD3ABC

Q35818801-12DA3421-8ADA-487E-B840-42B7D7C69EE9

Q35818801-1477CEB2-F501-4C33-966A-0B6FC42A9ED2

Q35818801-18B93E14-84F6-45B5-AD0E-FAE0DB8A08F6

Q35818801-212227EE-7D06-4F57-8810-FCEB5132C795

Q35818801-24AD7260-6FC2-412A-A9A4-914231033576

Q35818801-252B7C69-5151-4078-9A10-1FD42584F26C

Q35818801-2B878C6D-B604-4AB7-861D-B1ECE6E5FE1A

Q35818801-326F3516-3974-4102-8B71-7E0807904105

P304

Q35818801-051920E3-5C89-49BD-A2F8-7032655072F4

P31

Q35818801-0564464A-535B-44A4-B154-658E356E93BF

P356

Q35818801-AA7EA2EA-B518-4117-9129-C36842E10A8D

P407

Q35818801-8FE1B71B-C255-423B-8B9F-E830DB4FD1BD

P433

Q35818801-DFA1C4D5-ACD8-452C-9E7C-1DF7A68DFF4E

P478

Q35818801-4DED4DAA-8F6C-4918-9BED-42C860DDDEA8

P50

Q35818801-522C278D-CE35-4796-B61E-EABBFC45E46E

P577

Q35818801-0AFA193E-91B9-45BC-963A-D53F383848A9

P698

Q35818801-18FE7B31-3233-47B8-86B2-14C9CC36D73B

P932

Q35818801-D710ABD9-8DF2-4944-9CF8-EA64B3F5B6C5

P356

PNAS.1420005112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Deregulation of the Hippo path ...... 1 expression and tumorigenesis

@en

P2093

Kyung Min Park

http://www.w3.org/2001/XMLSchema#string

M Celeste Simon

http://www.w3.org/2001/XMLSchema#string

Mercy Gohil

http://www.w3.org/2001/XMLSchema#string

Michael S Nakazawa

http://www.w3.org/2001/XMLSchema#string

Nicolas Skuli

http://www.w3.org/2001/XMLSchema#string

Sam S Yoon

http://www.w3.org/2001/XMLSchema#string

Sharon Gerecht

http://www.w3.org/2001/XMLSchema#string

T S Karin Eisinger-Mathason

http://www.w3.org/2001/XMLSchema#string

Timothy P Cash

http://www.w3.org/2001/XMLSchema#string

Vera Mucaj

http://www.w3.org/2001/XMLSchema#string

P2860

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

TEAD mediates YAP-dependent gene induction and growth control

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

The hippo signaling pathway in development and cancer

Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor

The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members

Gene expression-based classification of non-small cell lung carcinomas and survival prediction

Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development

Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma

FoxM1 is a general target for proteasome inhibitors.

P304

E3402-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1420005112

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26080399

http://www.w3.org/2001/XMLSchema#string

P932

4491775

http://www.w3.org/2001/XMLSchema#string